fashion -WSS

fashion

author：comprehensive 2025-09-29 19:58:14 - browse：8

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Hey, doctors: Don't be no

hotspot

entertainment

WSS

Beam Therapeutics to lay off 20% of its staff, re

First Opinion Podcast: Long Covid needs a new approach

Prosecutors say FTX founder Sam Bankman

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Eli Lilly expects to double planned employment in Boston center

Medicare reduced heart disease by changing how it pays doctors

entertainment

fashion

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

In age of alternative facts, a scholarly course on calling out crap

Why health workers in Gaza are injured or die at high rates

Duchenne breakthrough therapy leaves behind pioneering families

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

As demand for Covid shots wanes, Moderna seeks its next success

What is artificial intelligence? Experts weigh in

Peter Hotez and the public health issue of online harassment

Solve the antibiotic resistance crisis with preventive drugs

explore

Solve the antibiotic resistance crisis with preventive drugs

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

'The View' co

The explosion of genetic testing requires a new approach

First Opinion Podcast: Long Covid needs a new approach

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Wikipedia

hotspot

entertainment

Wikipedia